Trials / Completed
CompletedNCT00053547
Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 2 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if Zemplar, a vitamin D medication, safely and effectively decreases parathyroid hormone in children ages 2-20 with End Stage Renal Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paricalcitol injection |
Timeline
- Start date
- 2002-01-01
- First posted
- 2003-02-03
- Last updated
- 2006-08-02
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00053547. Inclusion in this directory is not an endorsement.